1.Values of Serum Pepsinogen and Gastrin-17 in Screening Gastric Cancer and Gastric Precancerous Lesion
Mengying LI ; Chen MA ; Chenyang JIAO ; Weichang CHEN
Chinese Journal of Gastroenterology 2017;22(9):539-543
Background:China is an area with high incidence of gastric cancer,studies have shown that serum pepsinogen (PG) and gastrin-17 (G-17)levels can be used for gastric cancer screening. Aims:To investigate the values of serum PG and G-17 levels in screening gastric precancerous lesion and gastric cancer. Methods:A total of 211 patients with gastroduodenal disease diagnosed by endoscopy and biopsy from March 2016 to October 2016 at the First Affiliated Hospital of Soochow University were enrolled,and 67 healthy subjects were served as controls. Serum levels of PGⅠ,PGⅡ,G-17 and Hp-IgG antibodies were determined by ELISA. Results:Compared with control group,PGⅠ level and PGR were significantly decreased in atrophic gastritis group (P < 0. 01);serum PGⅠ level and PGR were significantly decreased, and G-17 level was significantly increased in low grade intraepithelial neoplasia group,high grade intraepithelial neoplasia group and gastric cancer group (P < 0. 01). ROC curve showed that the best cutoff values of PGⅠ,PGR and G-17 for diagnosing gastric cancer and gastric precancerous lesion were 74. 74 ng/ mL (sensitivity 88. 3%,specificity 78. 0%), 6. 59 (sensitivity 87. 0%,specificity 73. 8%),13. 02 pmol/ L (sensitivity 54. 2%,specificity 84. 4%),respectively. PGR and G-17 were the independent predictors of gastric cancer and gastric precancerous lesion. The sensitivity and specificity of combined detection of PGⅠ,PGR and G-17 for diagnosing gastric precancerous lesion and gastric cancer were 89. 9% and 84. 4%,respectively. Conclusions:Serum PGⅠ,PGR and G-17 may be used as indicators of gastric cancer and gastric precancerous lesion screening. PG combined with G-17 for diagnosing gastric cancer and gastric precancerous lesion is more sensitive and specific than using serum PG or G-17 alone.
2.Risk factor analysis of recurrent acute pancreatitis
Chenyang JIAO ; Mengying LI ; Chen MA ; Weichang CHEN
Chinese Journal of Digestion 2017;37(4):249-253
Objective To analyze the clinical features and risk factors of recurrent acute pancreatitis (RAP).Methods From September 2012 to September 2014,the clinical data of 411 patients with primary acute pancreatitis (AP) were collected.From March to June 2016,patients were followed up.The clinical features of patients with RAP were analyzed.Univariate and multivariate regression analysis were performed to analyze the risk factors of RAP.Results Among the 411 patients with AP,those caused by biliary disease,hyperlipidemia,alcohol,other known causes and idiopathic AP were 265 cases (64.5%),61 cases (14.8%),19 cases (4.6%),21 cases (5.1%) and 45 cases (10.9%),respectively.In two weeks of AP onset,the recurrent rate of biliary AP in cholecystectomy group was 7.1% (5/70),which was lower than that of non-cholecystectomy group (30.2%,42/139),and the difference was statistically significant (xz =14.218,P<0.01).The results of univariate regression analysis suggested that gender,body mass index (BMI),complicated with diabetes,etiology,history of smoking,history of drinking and pancreatic necrosis were correlated with RAP (all P<0.05).The results of multivariate regression analysis indicated that complicated with diabetes (odd ratios (OR) =3.417,95 % confidence interval (CI) 1.979 to 5.900,P<0.01),hyperlipidemic pancreatitis (OR=2.247,95%CI 1.077 to 4.688,P=0.023),history of smoking (OR=4.023,95%CI 2.377 to 6.809,P<0.01),complicated with pancreatic necrosis (OR=3.312,95% CI 1.675 to 6.546,P<0.01) were independent risk factors of RAP.Conclusions Hypertriglyceridemia,smoking,complicated with pancreatic necrosis and diabetes are independent risk factors of RAP.Patients with biliary AP should receive cholecystectomy as early as possible,which could reduce RAP.
3.An overview on sleep research based on functional near infrared spectroscopy.
Mengying HUANG ; Xuejun JIAO ; Jin JIANG ; Jiehong YANG ; Hongzuo CHU ; Jinjin PAN ; Yong CAO
Journal of Biomedical Engineering 2021;38(6):1211-1218
Sleep is a complex physiological process of great significance to physical and mental health, and its research scope involves multiple disciplines. At present, the quantitative analysis of sleep mainly relies on the "gold standard" of polysomnography (PSG). However, PSG has great interference to the human body and cannot reflect the hemodynamic status of the brain. Functional near infrared spectroscopy (fNIRS) is used in sleep research, which can not only meet the demand of low interference to human body, but also reflect the hemodynamics of brain. Therefore, this paper has collected and sorted out the related literatures about fNIRS used in sleep research, concluding sleep staging research, clinical sleep monitoring research, fatigue detection research, etc. This paper provides a theoretical reference for scholars who will use fNIRS for fatigue and sleep related research in the future. Moreover, this article concludes the limitation of existing studies and points out the possible development direction of fNIRS for sleep research, in the hope of providing reference for the study of sleep and cerebral hemodynamics.
Brain/diagnostic imaging*
;
Hemodynamics
;
Humans
;
Polysomnography
;
Sleep
;
Spectroscopy, Near-Infrared
5.Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy.
Yijun CHEN ; Kaiming LI ; Mengying JIAO ; Yingshuang HUANG ; Zihao ZHANG ; Lingjing XUE ; Caoyun JU ; Can ZHANG
Acta Pharmaceutica Sinica B 2023;13(2):787-803
Rheumatoid arthritis (RA) is an autoimmune disease characterized by severe synovial inflammation and cartilage damage. Despite great progress in RA therapy, there still lacks the drugs to completely cure RA patients. Herein, we propose a reprogrammed neutrophil cytopharmaceuticals loading with TNFα-targeting-siRNA (siTNFα) as an alternative anti-inflammatory approach for RA treatment. The loaded siTNFα act as not only the gene therapeutics to inhibit TNFα production by macrophages in inflamed synovium, but also the editors to reprogram neutrophils to anti-inflammatory phenotypes. Leveraging the active tendency of neutrophils to inflammation, the reprogrammed siTNFα/neutrophil cytopharmaceuticals (siTNFα/TP/NEs) can rapidly migrate to the inflamed synovium, transfer the loaded siTNFα to macrophages followed by the significant reduction of TNFα expression, and circumvent the pro-inflammatory activity of neutrophils, thus leading to the alleviated synovial inflammation and improved cartilage protection. Our work provides a promising cytopharmaceutical for RA treatment, and puts forward a living neutrophil-based gene delivery platform.